Diabetes mellitus as a primary manifestation of multiple endocrine neoplasia type 2B

Acta Chirurgica Belgica

Volumn 108, Issue 6, 2008, Pages 732-737

  Donckier, J E ^a   Rosiere A ^a   Heureux, F ^a   Michel, L ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Diabetes mellitus; Ganglioneuroma; Medullary thyroid carcinoma; Multiple endocrine neoplasia type 2B; Phaeochromocytoma

Indexed keywords

EID: 58649119273     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2008.11680325     Document Type: Article

References (26)

1. BRANDY M. L., GAGEL R. F., ANCELI A., BILEZIKIAN J. P., BECK-PECCOZ P. et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Melab, 2001, 86: 5658-5671.
2. LENDERS J. W. M., EISENHOFER G., MANELLI M., PACAK K. Phaeochromocytoma. Lancet, 2005, 366: 665-675.
3. GAGEL R. F., MARX S. J. Multiple endocrine neoplasia. In: LARSEN P. R., KRONENBERG H. M., MELMED S., POLONSKY K. S. (eds.). Williams Textbook of Endocrinology, Philadelphia: Saunders, 2003: 1717-62.
4. KARAGIANNIS A., MIKHAILIDIS D. P., ATHYROS V. G., HARSOULIS F. Pheochromocytoma: an update on genetics and management. Endocrine-related Cancer, 2007, 14: 935-956.
5. LEE N. C., NORTON J. A. Multiple endocrine neoplasia type 2B-genetic basis and clinical expression. Surg Oncol, 2000, 9: 111-118.
6. BRAUCKHOFF M., GIMM O., WEIS C. L., UKKAT J., SEKULLA C., BRAUCKHOFF K., NGUYEN THANH P., DRALLE H. Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg, 2004, 28: 1305-1311.
7. DONCKIER J. E. Endocrine diseases and diabetes. In: WILLIAMS G., PICKUP J. C. (eds.). Texbook of Diabetes, Oxford: Blackwell Science, 2003: 27.1-27.25.
8. NESTLER J. E., MCCLANAHAN M. A. Diabetes and the adrenal disease. Baillière's Clin Endocrinol Metab, 1992, 6: 829-47.
9. CRYER P. E. Catecholamines, phaeochromocytoma and diabetes. Diabetes Rev, 1993, 1: 309-17.
10. WIESNER T. D., BLÜHER M., WINDGASSEN M., PASCHKE R. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Endocrinol Metab, 2003, 88: 3632-3636.
11. LA BATIDE-ALANORE A., CHATELLIER G., PLOUIN P. F. Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertension, 2003, 21: 1703-1707.
12. TONG C., ENGLAND P., CHAMPION DE CRESTIGNY P., MILLAR R., CONN J. Diabetes mellitus as the only manifestation of occult phaeochromocytoma prior to acute haemorrhage in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005, 45: 91-92.
13. STENTRÖM G., SJÖSTRÖM L., SMITH U. Diabetes in pheochromocytoma: fasting blood glucose levels before and after surgery in 60 patients with pheochromocytoma. Acta Endocrinol (Copenh), 1984, 106: 511-515.
14. PORTE D. J. A receptor mechanism for the inhibition of insulin release by epinephrine. J Clin Invest, 1967, 46: 86-94.
15. ISLES C. G., JOHNSON J. K. Pheochromocytoma and diabetes mellitus: further evidence that a-2 receptors inhibit insulin release in man. Clin Endocrinol, 1983, 18: 37-4.
16. SACCA L., VIGRITO C., CICALA M., CORSO G., SHERWIN R. S. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol, 1983, 245: E294-302.
17. DIEBERT D. C., DE FRONZO R. A. Epinephrine-induced insulin resistance in man. J Clin Invest, 1980, 65: 1717-21.
18. HOFSTRA R. M., LANDSVATER R. M., CECCHERINI I., STULP R. P., STELWAGEN T., LUO Y., PASINI B., HOPPENER J. W., VAN AMSTEL H. K., ROMEO G., LIPS C. J., BUYS C. H. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature, 1994, 367: 375-376.
19. CARLSON K. M., BRACAMONTES J., JACKSON C. E., CLARK R., LACROIX A., WELLS S. A., GOODFELLOW P. J. Parent-of-origin effects in multiple endocrine neoplasia type 2B. American Journal of Human Genetics, 1994, 55: 1076-1082.
20. WRAY C. J., RICH T. A., WAGUESPACK S. G., LEE J. E., PERRIER N. D., EVANS D. B. Failure to recognize multiple endocrine neoplasia 2B: more common than we think? Ann Surg Oncol, 2008, 15: 2093-301.
21. CARNEY J. A., SIZEMORE G. W., LOVESTEDT S.A. Mucosal ganglioneuromatosis, medullary thyroid and pheochromocytoma: multiple endocrine neoplasia type 2b. Oral Surg Oral Med Oral Pathol, 1976, 41: 739-752.
22. BARWICK K. W. Gastrointestinal manifestations of multiple endocrine neoplasia, type IIB. J Clin Gastroenterol, 1983, 5: 83-87.
23. COL V., DE CANNIÈRE L., COLLARD E., MICHEL L., DONCKIER J. E. Laparoscopic adrenalectomy for phaeochromocytoma: endocrinological and surgical aspects of a new therapeutic approach. Clin Endocrinol, 1999, 50: 121-25.
24. MICHEL L. A., DONCKIER J. E. Importance of secretion pattern in minimally invasive surgery for phaeochromocytoma. Clin Endocrinol, 2006, 66: 455-6.
25. VAN HEERDEN J. A., SIZEMORE G. W., CARNEY J. A., GRAND J. S., RE MINE W. H., SHEPS S. G. Surgical management of the adrenal glands in multiple endocrine neoplasia type II syndrome. World J Surg, 1984, 8: 612-621.
26. LEWIS C. E., YEH M. W. Inherited endocrinopathies; an update. Mol Genet Metab, 2008, 94: 271-82.